#Germany #Oberkochen #Mindpeak #Revolune #Multiplex

Revolutionizing Spatial Biology in Cancer Research

At the AACR 2026 annual meeting, a significant collaboration was unveiled by Revolune GmbH and MindPeak, two pioneering companies in the life sciences arena. This partnership aims to integrate advanced multiplex immunofluorescence reagents with AI-driven image analysis, paving the way for a more streamlined and efficient workflow in spatial biology.

Simplifying Complex Workflows

Both companies recognized the inherent complexity within traditional multiplex workflows in spatial biology. While multiplex immunofluorescence has become a crucial tool for unraveling tumor biology, immune interactions, and the spatial context of biomarkers, many researchers still find the existing techniques to be technically challenging and often inaccessible.

Revolune’s contribution focuses on its advanced multiplex immunofluorescence (mIF) reagents tailored to deliver clarity, speed, and reliability. Coupling this with MindPeak's AI-powered pathology software enhances the overall capability of researchers to derive meaningful biological insights from high-quality multiplex tissue data. Through this integration, scientists can move seamlessly from tissue sample processing to practical biological comprehension.

Florian Leiss, CEO of Revolune, emphasized the critical nature of robust experimental workflows alongside reliable data interpretation in spatial biology. By merging Revolune's mIF chemistry with MindPeak's exceptional AI analytics, the goal is to simplify the journey from tissue samples to actionable spatial knowledge.

AI-Driven Analysis for Enhanced Accuracy

MindPeak's software autonomously handles the complexities of multiplex imaging data, providing functionalities that promote quantitative biomarker evaluation and spatial interpretation of intricate tissue samples. This capability not only speeds up the research process but also significantly reduces the room for human error, which is often a limiting factor in laboratory settings.

Felix Faber, CEO of MindPeak, expressed enthusiasm about this collaboration, highlighting a shared goal to eliminate hurdles that frequently hinder the adoption of spatial biology workflows. By making these innovative solutions more accessible, both companies hope to create a significant impact in the field of translational cancer research and biomarker discovery.

Insights and Networking at AACR 2026

Attendees of the AACR 2026 will have the unique opportunity to learn more about this integrated workflow, as Revolune and MindPeak will be available at booth 1660. They invite researchers and academic professionals to discuss how their combined solutions for staining and analysis can propel forward the field of cancer research, enabling easier transitions from fundamental discoveries to clinical applications.

About Revolune

Revolune is dedicated to furthering the frontiers of spatial biology through innovative multiplex immunofluorescence solutions designed to facilitate the process of immunohistochemistry (IHC). With an emphasis on developing reagents that champion clarity and accuracy, Revolune empowers researchers to explore critical biological data within complex tissue systems, making translations into biopharmaceutical research more seamless.

For more information, visit Revolune's official website.

About MindPeak

MindPeak stands as a leader in AI-driven digital pathology, effectively bridging the gap between biomarker development and clinical diagnostics. Established in 2018, the company’s AI technology aids laboratories in extracting actionable insights from HE, IHC, and mIF tissue images, ranging from the quantification of subcellular biomarkers to predictive patient stratification. MindPeak’s solutions are instrumental in both current diagnostics and in facilitating the translation of new biomarkers into practical clinical contexts.

For more insights, visit MindPeak's website or follow their updates on LinkedIn.